Reporting owner · Q3 2026 · CIK 2069137

Shao Wei-Li: insider trades.

Shao Wei-Li reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($546K), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
Shao Wei-Li

Companies

CompanyRelationshipTransactions
Omada Health, Inc. (OMDA)Officer · President6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-10Omada Health, Inc.S3,636$21.78295,713Form 4
2026-09-10Omada Health, Inc.S400$22.53295,313Form 4
2026-09-05Omada Health, Inc.F1,843$22.77299,349Form 4
2026-09-01Omada Health, Inc.F6,180$22.84301,192Form 4
2026-08-12Omada Health, Inc.S9,418$25.02307,372Form 4/A
2026-08-12Omada Health, Inc.S8,866$25.02307,372Form 4

Questions

What stock did Shao Wei-Li buy or sell?

Shao Wei-Li reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($546K), across 1 company.

Is Shao Wei-Li the same person as other filers with this name?

This page covers SEC CIK 2069137 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/shao-wei-li-2069137.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.